Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03662295 · ClinicalTrials.gov registry record
Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention
A clinical trial of Aphasia and Migraine Disorders, sponsored by Quality Living.
- Completed
- Registry status
- 1
- Enrollment target
- 1
- Study location
NCT03662295: Completed study of Aphasia and Migraine Disorders, sponsored by Quality Living.
NCT03662295 is a study of Aphasia and Migraine Disorders that has completed, run by Quality Living. The registered enrollment target is 1 participants, below the 83-participant average among 42 other Aphasia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03662295, a study of Aphasia and Migraine Disorders, has completed, sponsored by Quality Living.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
- 1
- Study location
Study Summary
Stroke-like migraine attacks after radiation therapy-also known as SMART syndrome-constitute a rare condition typically characterized by headache, seizures, vision abnormalities, hemiparesis, and aphasia. The condition usually resolves within a few days or weeks of onset with no residual impairments. However, resolution in some cases extends over a period of months rather than weeks and may be incomplete. The purpose of this case report is to provide an in-depth description of the progression of changes in cognitive and language functioning for a person exhibiting SMART syndrome characterized by slow recovery.
Primary Outcome
Aphasia Quotient of the Western Aphasia Battery - Revised
Conditions Studied
Interventions
- BEHAVIORAL Language treatment
Study Locations (1)
Nebraska
- Quality Living, Inc. - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-09-03 |
| Est. Completion | 2019-11-13 |
What the finished NCT03662295 record still lists
NCT03662295 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 83-participant average among 42 other Aphasia trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Aphasia appearing as the primary indexed condition, and to 1 intervention - of which Language treatment is the first listed.
NCT03662295 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT03662295 about?
NCT03662295 is a clinical study titled "Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention". Stroke-like migraine attacks after radiation therapy-also known as SMART syndrome-constitute a rare condition typically characterized by headache, seizures, vision abnormalities, hemiparesis, and aphasia. The condition usually resolves within a few days or weeks of onset with no residual impairments...
What is the current status of trial NCT03662295?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2018-09-03. Estimated completion is 2019-11-13.
What conditions does trial NCT03662295 study?
This clinical trial studies the following conditions: Aphasia, Migraine Disorders.
What interventions are being tested in trial NCT03662295?
The interventions under investigation include: Language treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT03662295?
This trial is sponsored by Quality Living, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03662295 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aphasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03662295's enrollment target sits among peer trials
1 43rd of 42 the lowest of 42 other Aphasia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aphasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Comparing Traditional Semantic Feature Analysis (tSFA) and Semantic Feature Analysis + Metacognitive Strategy Training (SFA+MST)
RECRUITING · Phase 2
-
Transcranial Alternating Current Stimulation (tACS) in Aphasia
RECRUITING · NA
-
tACS to Enhance Language Abilities
RECRUITING · NA
-
Treatment Outcomes With tDCS in Post-Stroke Aphasia
RECRUITING · NA
-
Balancing Effortful and Errorless Learning in Naming Treatment for Aphasia
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI